Cargando…
Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
In the last decade, non-vitamin K antagonist oral anticoagulants (NOACs), a new generation of OACs, were introduced to prevent thromboembolism in patients with atrial fibrillation. Although vitamin K-dependent anticoagulants have long been used as OACs, their inherent disadvantage of considerable bl...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493442/ https://www.ncbi.nlm.nih.gov/pubmed/37680096 http://dx.doi.org/10.3904/kjim.2023.035 |